Citadel Advisors’s iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN SGG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,161
Closed -$253K 15608
2021
Q3
$253K Hold
4,161
﹤0.01% 11459
2021
Q2
$232K Buy
+4,161
New +$220K ﹤0.01% 11848
2020
Q3
Sell
-5,794
Closed -$221K 11250
2020
Q2
$221K Buy
+5,794
New +$203K ﹤0.01% 8386
2020
Q1
Sell
-6,730
Closed -$284K 10681
2019
Q4
$284K Buy
+6,730
New +$270K ﹤0.01% 7669
2019
Q3
Sell
-5,259
Closed -$209K 10257
2019
Q2
$226K Buy
5,259
+508
+11% +$21.7K ﹤0.01% 8020
2019
Q1
$208K Buy
+4,751
New +$209K ﹤0.01% 8167
2018
Q4
Sell
-7,472
Closed -$331K 10378
2018
Q3
$286K Buy
+7,472
New +$296K ﹤0.01% 7650

Citadel Advisors's SGG Position: Q4 2021 in Review

Citadel Advisors sold out of iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN (SGG) in Q4 2021, closing a stake of 4,161 shares — an estimated $253K sold.

Citadel Advisors first reported a position in SGG in Q3 2018 and held it in 7 quarters. The position peaked at $286K in Q3 2018. 11 funds tracked by Wall St. Rank hold SGG as of Q4 2021.

  • Citadel Advisors reported no remaining iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position as of Q4 2021 after selling out during the quarter.
  • Citadel Advisors sold 4,161 iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN shares in Q4 2021, an estimated $253K.
  • Citadel Advisors first reported a position in iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN in Q3 2018 and held it in 7 quarters.
  • Citadel Advisors's iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position peaked at $286K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.